サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1388172

ヒト血小板溶解物（hPL）市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2032年

Human Platelet Lysate Market Share, Size, Trends, Industry Analysis Report, By Type (Heparin Based HPL, Heparin Free HPL); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヒト血小板溶解物（hPL）市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年10月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris market researchの最新調査によると、ヒト血小板溶解物（hPL）の世界市場規模は2032年までに7,474万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ヒト血小板溶解物（hPL）は、細胞培養や再生医療用途に使用される生物学的由来の製品です。血液凝固や創傷治癒に関与する血液細胞の一種であるヒト血小板を加工して作られます。hPLには様々な成長因子や生理活性分子が含まれており、細胞の成長を促進し、様々な種類の細胞に栄養豊富な環境を提供します。

パーキンソン病、変形性関節症、男性型脱毛症などの慢性疾患の増加は、血小板溶解物市場に大きな影響を与えています。これらの慢性疾患は、革新的で効果的な治療オプションに対する需要の高まりにつながり、再生医療における研究開発を促進し、それによって血小板溶解物市場に影響を与えています。

効率性もhPLの採用を後押しする説得力のある要因です。hPLは細胞の増殖、生存率、機能性をサポートするという点で、しばしばFBSを凌駕することが研究で示されています。研究者らは、hPLを使用することで、より頑健で信頼性の高い実験結果が得られるため、細胞増殖率が向上し、細胞機能が改善することを観察してきました。この効率性の向上は、培養細胞の品質が治療や治療の成功に直接影響する再生医療のような分野で特に価値があります。

遺伝性の脱毛症である男性型脱毛症もまた、血小板溶解物ベースのソリューションへの関心を高めています。例えば、米国では約5,000万人の男性と3,000万人の女性が男性型脱毛症の影響を受けていると考えられています。この症状は、早ければ10代から始まり、年齢を重ねるにつれて起こりやすくなります。50歳を超えると、男性の50％以上がある程度の脱毛を経験します。米国保健福祉省によると、女性の場合、脱毛は閉経後に多くなる傾向があります。血小板溶解物に由来する多血小板血漿（PRP）は、毛包の再生を促し、発毛を促進することが期待されています。脱毛に対して効果的で非侵襲的な治療法を求める人々が増えているため、血小板溶解物に基づく毛髪再生術の市場は大幅に拡大しています。

このような特定の症状だけでなく、慢性疾患や加齢に伴う健康問題の幅広い増加により、根本的な原因に対処し、長期的な救済を提供できる再生療法に対する需要が生じています。下のグラフは、新しい再生医療や治療法の開発を促す慢性疾患の増加を予測したものです。再生特性を持つ血小板溶解物は、損傷した組織を修復し、免疫反応を調整し、全体的な患者の転帰を改善することを目的とした細胞ベースの治療法の開発における貴重なツールとなっています。

ヒト血小板溶解物（hPL）市場レポートハイライト

2022年には、ヘパリン含有製品の代替品としての安全性、信頼性、有効性により、ヘパリンフリーhPLセグメントが最大の収益シェアを占めました。

治療分野は、再生医療、創傷治癒、眼科、神経疾患、さらにはがん治療など、多様で有望な用途があることから、予測期間中に最も速い市場成長が見込まれます。その多用途性と様々な治療アプローチを強化する可能性により、特定の臨床状況では慎重な検討が必要ではあるが、医学研究と臨床の分野で貴重なツールとなっています。

2022年には、生物医学研究、再生医療、細胞治療技術の進歩における重要な役割に重点が置かれている北米が、最大市場を独占しました。規制当局の監督により、こうした革新的な治療法の倫理的かつ安全な開拓が保証されるため、北米はhPLの世界市場における主要なプレーヤーとなっています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のヒト血小板溶解物（hPL）市場に関する洞察

  • ヒト血小板溶解物（hPL）市場- 最終用途のスナップショット
  • ヒト血小板溶解物（hPL）市場力学
    • 促進要因と機会
      • 大手企業や政府による幹細胞治療の研究開発（R&D）活動が増加
      • パーキンソン病、変形性関節症、男性型脱毛症などの慢性疾患の有病率の増加
    • 抑制要因と課題
      • コストが高く、伝染病の伝播リスクが増加
  • PESTEL分析
  • ヒト血小板溶解物（hPL）市場の最終用途動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のヒト血小板溶解物（hPL）市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • ヘパリンベースhPL
  • ヘパリンフリーhPL

第6章 世界のヒト血小板溶解物（hPL）市場、用途別

  • 主な調査結果
  • イントロダクション
  • 研究
  • 治療

第7章 世界のヒト血小板溶解物（hPL）市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • その他

第8章 世界のヒト血小板溶解物（hPL）市場、地域別

  • 主な調査結果
  • イントロダクション
    • ヒト血小板溶解物（hPL）市場評価、地域別、2019-2032年
  • ヒト血小板溶解物（hPL）市場-北米
    • 北米：ヒト血小板溶解物（hPL）市場、タイプ別、2019-2032年
    • 北米：ヒト血小板溶解物（hPL）市場、最終用途別、2019-2032年
    • 北米：ヒト血小板溶解物（hPL）市場、用途別、2019-2032年
    • ヒト血小板溶解物（hPL）市場-米国
    • ヒト血小板溶解物（hPL）市場- カナダ
  • ヒト血小板溶解物（hPL）市場- 欧州
    • 欧州：ヒト血小板溶解物（hPL）市場、タイプ別、2019～2032年
    • 欧州：ヒト血小板溶解物（hPL）市場、最終用途別、2019-2032
    • 欧州：ヒト血小板溶解物（hPL）市場、用途別、2019～2032年
    • ヒト血小板溶解物（hPL）市場- 英国
    • ヒト血小板溶解物（hPL）市場- フランス
    • ヒト血小板溶解物（hPL）市場- ドイツ
    • ヒト血小板溶解物（hPL）市場- イタリア
    • ヒト血小板溶解物（hPL）市場- スペイン
    • ヒト血小板溶解物（hPL）市場- オランダ
    • ヒト血小板溶解物（hPL）市場- ロシア
  • ヒト血小板溶解物（hPL）市場- アジア太平洋
    • アジア太平洋：ヒト血小板溶解物（hPL）市場、タイプ別、2019～2032年
    • アジア太平洋：ヒト血小板溶解物（hPL）市場、最終用途別、2019～2032年
    • アジア太平洋：ヒト血小板溶解物（hPL）市場、用途別、2019～2032年
    • ヒト血小板溶解物（hPL）市場- 中国
    • ヒト血小板溶解物（hPL）市場- インド
    • ヒト血小板溶解物（hPL）市場- マレーシア
    • ヒト血小板溶解物（hPL）市場- 日本
    • ヒト血小板溶解物（hPL）市場- インドネシア
    • ヒト血小板溶解物（hPL）市場- 韓国
  • ヒト血小板溶解物（hPL）市場-中東およびアフリカ
    • 中東およびアフリカ：ヒト血小板溶解物（hPL）市場、タイプ別、2019-2032年
    • 中東およびアフリカ：ヒト血小板溶解物（hPL）市場、最終用途別、2019～2032年
    • 中東およびアフリカ：ヒト血小板溶解物（hPL）市場、用途別、2019～2032年
    • ヒト血小板溶解物（hPL）市場- サウジアラビア
    • ヒト血小板溶解物（hPL）市場- アラブ首長国連邦
    • ヒト血小板溶解物（hPL）市場- イスラエル
    • ヒト血小板溶解物（hPL）市場- 南アフリカ
  • ヒト血小板溶解物（hPL）市場-ラテンアメリカ
    • ラテンアメリカ：ヒト血小板溶解物（hPL）市場、タイプ別、2019-2032年
    • ラテンアメリカ：ヒト血小板溶解物（hPL）市場、最終用途別、2019-2032
    • ラテンアメリカ：ヒト血小板溶解物（hPL）市場、用途別、2019-2032年
    • ヒト血小板溶解物（hPL）市場- メキシコ
    • ヒト血小板溶解物（hPL）市場- ブラジル
    • ヒト血小板溶解物（hPL）市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AventaCell BioMedical Corp
  • Compass Biomedical Inc.
  • Lifescience Group Limited
  • Macopharma SA
  • Merck KGaA
  • Mill Creek Lifesciences LLC
  • Sclavo Diagnostics International Srl
  • Stem Cell Technologies Inc
  • Trinova Biochem GmbH
  • Zen Bio, Inc.
図表

List of Tables

  • Table 1 Global Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 4 Human Platelet Lysate Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 6 North America: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 8 U.S.: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 11 Canada: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 12 Canada: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 14 Europe: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 15 Europe: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 17 UK: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 18 UK: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 20 France: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 21 France: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 23 Germany: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 24 Germany: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 26 Italy: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 27 Italy: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 29 Spain: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 30 Spain: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 32 Netherlands: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 35 Russia: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 36 Russia: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 41 China: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 42 China: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 44 India: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 45 India: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 47 Malaysia: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 50 Japan: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 51 Japan: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 53 Indonesia: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 56 South Korea: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 65 UAE: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 66 UAE: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 68 Israel: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 69 Israel: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 71 South Africa: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 74 Latin America: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 77 Mexico: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 80 Brazil: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • Table 83 Argentina: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Human Platelet Lysate Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Human Platelet Lysate Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Human Platelet Lysate Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global Human Platelet Lysate Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 12. Human Platelet Lysate Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Human Platelet Lysate Market
目次
Product Code: PM3990

The global human platelet lysate market size is expected to reach USD 74.74 million by 2032, according to a new study by Polaris market research. The report "Human Platelet Lysate Market Share, Size, Trends, Industry Analysis Report, By Type (Heparin Based HPL, Heparin Free HPL); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human Platelet Lysate (HPL) is a biologically derived product used in cell culture and regenerative medicine applications. It is created by processing human platelets, a type of blood cell involved in clotting and wound healing. HPL contains various growth factors and bioactive molecules that promote cell growth and provide a nutrient-rich environment for various cell types.

The increasing prevalence of chronic diseases, including but not limited to Parkinson's disease, osteoarthritis, and androgenetic alopecia, has significantly impacted the platelet lysate market. These chronic conditions have led to a growing demand for innovative and effective treatment options, driving research and development efforts in regenerative medicine and thereby, influencing the market for platelet lysate.

Efficiency is another compelling factor fueling the adoption of HPL. Studies have shown that HPL can often outperform FBS in terms of supporting cell growth, viability, and functionality. Researchers have observed enhanced cell expansion rates and improved cellular functions when using HPL, due to more robust and reliable experimental results. This heightened efficiency is particularly valuable in fields like regenerative medicine, where the quality of cultured cells directly impacts the success of therapies and treatments.

Androgenetic alopecia, a hereditary form of hair loss, has also driven interest in platelet lysate-based solutions. For instance, approximately 50 million men and 30 million women in the United States are believed to be impacted by androgenetic alopecia. This condition can commence as early as a person's teenage years and becomes more likely as they age. Beyond the age of 50, over 50 percent of men experience some level of hair loss. In the case of women, hair loss tends to be more common following menopause, according to U.S. Department of Health and Human Services. Platelet-rich plasma (PRP), derived from platelet lysate, has shown promise in stimulating hair follicle regeneration and promoting hair growth. As individuals seek effective and non-invasive treatments for hair loss, the market for platelet lysate-based hair restoration procedures has grown substantially.

Beyond these specific conditions, the broader rise in chronic diseases and age-related health issues has created a demand for regenerative therapies that can address the root causes and provide long-term relief. The below graph predicts the rising number of chronic diseases that urge for developing new regenerative medicines and therapies. Since Platelet lysate, with its regenerative properties, has become a valuable tool in the development of cell-based treatments that aim to repair damaged tissues, modulate immune responses, and improve overall patient outcomes.

Human Platelet Lysate Market Report Highlights

In 2022, the heparin free HPL segment held the largest revenue share due to its safety, reliability, and effectiveness as an alternative to heparin-containing products.

The therapeutic segment expected to witness the fastest market during the forecast period due to its diverse and promising applications in regenerative medicine, wound healing, ophthalmology, neurological disorders, and even cancer therapy. Its versatility and potential to enhance various therapeutic approaches make it a valuable tool in the field of medical research and clinical practice, albeit with careful consideration in certain clinical contexts.

In 2022, North America dominated the largest market due to region's focus on biomedical research, regenerative medicine, and its significant role in advancing cell therapy techniques. Regulatory oversight ensures the ethical and safe development of these innovative therapies, making North America a key player in the global market for HPL.

The global key market players include: Merck KGaA, Compass Biomedical Inc., AventaCell BioMedical Corp, Mill Creek Lifesciences LLC, Stem Cell Technologies Inc., Zen Bio, Inc., Sclavo Diagnostics International Srl, Lifescience Group Limited, and Trinova Biochem GmbH.

Polaris market research has segmented the human platelet lysate market report based on type, application, end-use, and region:

Human Platelet Lysate, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Heparin Based HPL
  • Heparin Free HPL

Human Platelet Lysate, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Research
  • Therapeutic

Human Platelet Lysate, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnological Companies
  • Academic & Research Institutes
  • Others

Human Platelet Lysate, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Platelet Lysate Market Insights

  • 4.1. Human Platelet Lysate Market - End-Use Snapshot
  • 4.2. Human Platelet Lysate Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing In the Research and Development (R&D) Activities of Stem Cell Therapy by Major Companies and Governments
      • 4.2.1.2. Increasing prevalence of chronic diseases such as Parkinson's disease, osteoarthritis, androgenetic alopecia and others
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and increased risk of transmission of infectious communicable diseases
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Human Platelet Lysate Market End-Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Human Platelet Lysate Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
  • 5.3. Heparin Based HPL
    • 5.3.1. Global Human Platelet Lysate Market, by Heparin Based HPL, by Region, 2019-2032 (USD Million)
  • 5.4. Heparin Free HPL
    • 5.4.1. Global Human Platelet Lysate Market, by Heparin Free HPL, by Region, 2019-2032 (USD Million)

6. Global Human Platelet Lysate Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • 6.3. Research
    • 6.3.1. Global Human Platelet Lysate Market, by Research, by Region, 2019-2032 (USD Million)
  • 6.4. Therapeutic
    • 6.4.1. Global Human Platelet Lysate Market, by Therapeutic, by Region, 2019-2032 (USD Million)

7. Global Human Platelet Lysate Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
  • 7.3. Pharmaceutical & Biotechnological Companies
    • 7.3.1. Global Human Platelet Lysate Market, by Pharmaceutical & Biotechnological Companies, By Region, 2019-2032 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Global Human Platelet Lysate Market, by Academic & Research Institutes, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Human Platelet Lysate Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Human Platelet Lysate Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Human Platelet Lysate Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Human Platelet Lysate Market - North America
    • 8.3.1. North America: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.3. North America: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Human Platelet Lysate Market - U.S.
      • 8.3.4.1. U.S.: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Human Platelet Lysate Market - Canada
      • 8.3.5.1. Canada: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • 8.4. Human Platelet Lysate Market - Europe
    • 8.4.1. Europe: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.3. Europe: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Human Platelet Lysate Market - UK
      • 8.4.4.1. UK: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Human Platelet Lysate Market - France
      • 8.4.5.1. France: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.5.3. France: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Human Platelet Lysate Market - Germany
      • 8.4.6.1. Germany: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Human Platelet Lysate Market - Italy
      • 8.4.7.1. Italy: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Human Platelet Lysate Market - Spain
      • 8.4.8.1. Spain: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Human Platelet Lysate Market - Netherlands
      • 8.4.9.1. Netherlands: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Human Platelet Lysate Market - Russia
      • 8.4.10.1. Russia: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • 8.5. Human Platelet Lysate Market - Asia Pacific
    • 8.5.1. Asia Pacific: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Human Platelet Lysate Market - China
      • 8.5.4.1. China: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.4.3. China: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Human Platelet Lysate Market - India
      • 8.5.5.1. India: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.5.3. India: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Human Platelet Lysate Market - Malaysia
      • 8.5.6.1. Malaysia: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Human Platelet Lysate Market - Japan
      • 8.5.7.1. Japan: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Human Platelet Lysate Market - Indonesia
      • 8.5.8.1. Indonesia: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Human Platelet Lysate Market - South Korea
      • 8.5.9.1. South Korea: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • 8.6. Human Platelet Lysate Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Human Platelet Lysate Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Human Platelet Lysate Market - UAE
      • 8.6.5.1. UAE: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Human Platelet Lysate Market - Israel
      • 8.6.6.1. Israel: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Human Platelet Lysate Market - South Africa
      • 8.6.7.1. South Africa: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
  • 8.7. Human Platelet Lysate Market - Latin America
    • 8.7.1. Latin America: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Human Platelet Lysate Market - Mexico
      • 8.7.4.1. Mexico: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Human Platelet Lysate Market - Brazil
      • 8.7.5.1. Brazil: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Human Platelet Lysate Market - Argentina
      • 8.7.6.1. Argentina: Human Platelet Lysate Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Human Platelet Lysate Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Human Platelet Lysate Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AventaCell BioMedical Corp
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Compass Biomedical Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Lifescience Group Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Macopharma SA
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Merck KGaA
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Mill Creek Lifesciences LLC
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Sclavo Diagnostics International Srl
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Stem Cell Technologies Inc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Trinova Biochem GmbH
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Zen Bio, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development